Mice lacking MAP kinase phosphatase-1 have enhanced MAP kinase activity and resistance to diet-induced obesity.
Journal
  Cell metabolism.
Citation
  Cell Metab. 4(1):61-73
Publication date
  2006 Jul
Authors
  Wu JJ
Roth RJ
Anderson EJ
Hong EG
Lee MK
Choi CS
Neufer PD
Shulman GI
Kim JK
Bennett AM
Investigators
  Jason K. Kim
Grant agencies
  National Institute of Diabetes and Digestive and Kidney Diseases
National Cancer Institute
Grants
  NIDDK 2P30 DK34989
NIDDK P01-DK57751
NIDDK R01 DK-40936
NCI T32 CA09085
NIDDK U24-DK59635
MeSH headings
  Diet
Immediate-Early Proteins
JNK Mitogen-Activated Protein Kinases
Mitogen-Activated Protein Kinases
Obesity
Phosphoprotein Phosphatases
Protein Tyrosine Phosphatases
p38 Mitogen-Activated Protein Kinases
MeSH qualifiers
  deficiency
metabolism
prevention & control
Abstract
  The mitogen-activated protein kinases (MAPK) play critical roles in the pathogenesis of diabetes and obesity. The MAPKs are inactivated by MAPK phosphatases (MKPs) either in the cytosol or nucleus. Here we show that mice lacking the nuclear-localized MKP, MKP-1 (mkp-1(-/-)), have enhanced Erk, p38 MAPK and c-Jun NH(2)-terminal kinase (JNK) activities in insulin-responsive tissues as compared with wild-type mice. Although JNK promotes insulin resistance, mkp-1(-/-) mice exhibited unimpaired insulin-mediated signaling and glucose homeostasis. We reconciled these results by demonstrating that in mkp-1(-/-) mice, JNK activity was increased in the nucleus, but not the cytosol. Significantly, mkp-1(-/-) mice are resistant to diet-induced obesity due to enhanced energy expenditure, but succumb to glucose intolerance on a high fat diet. These results suggest that nuclear regulation of the MAPKs by MKP-1 is essential for the management of metabolic homeostasis in a manner that is spatially uncoupled from the cytosolic actions of the MAPKs.